Cardiometabolic conditions are still being managed in silos—and employers are falling behind. This session reframes the conversation—moving beyond GLP-1s to a comprehensive metabolic health strategy that integrates population risk identification, smart benefits design, and wraparound lifestyle interventions. Panelists will share what it takes to get ahead of metabolic disease before it becomes a major cost driver.